INSIGHTS ON DRUG DEVELOPMENT

• Developing A Quantitative Surrogate Peptide Assay

  Discover a streamlined LC-MS/MS workflow for Fc-containing therapeutics like dulaglutide to enable precise quantification with LLOQ as low as 1 ng/mL through automated, efficient assay development.

• Bioanalytical Quantification Of A Biotherapeutic Peptide

  Discover a sensitive, selective, and robust LC-MS method for quantifying semaglutide in plasma with advanced sample preparation and detection technologies for accurate results in bioanalytical research.

• Accelerating Small Molecule Development With Cutting-Edge Technology

  Discover Asymchem Sandwich, our advanced small molecule facility at Discovery Park, Kent. 

• Patented Process For Intermediates Useful For Deucravacitinib

  Discover how this patented synthetic approach to Deucravacitinib intermediates can improve yield, simplify purification, and support scalable, regulatory-aligned manufacturing.

• Efficiently Optimize Your Workflow With Single-Use Chromatography

  11/4/2025

  Explore how low-volume purification can be done more efficiently in GMP settings with a live system demo and customer insights on optimizing workflows with single-use chromatography.

• Streamline Your Workflow With An Innovative Fixed-Bed System

  11/4/2025

  Discover how an innovative fixed-bed system streamlines workflows and supports consistent, high-yield manufacturing across a range of applications.

• Ultra-Low Cross-Linked Microgel Purification

  2/24/2026

  ULC microgel purification is often slowed by linear polymer contamination and limitations of centrifugation. Explore how hollow fiber TFF improves filtration efficiency and supports scalable processing.

• Formulation Development Of Enterically Protected Spray Dried Dispersions

  11/17/2025

  Adrulipase spray-dried dispersions were evaluated to create an orally delivered, enteric-protected enzyme. The lead formulation provided the best acid protection, rapid release, and stability.

• Delivering Critical Therapies With Speed And Safety

  6/26/2026

  Faster approvals depend on treating regulation as part of development, not the finish line. See how early quality planning and strong agency communication can move therapies toward patients sooner.